Australia's most trusted
source of pharma news
Friday, 09 May 2025
Posted 9 May 2025 AM
The breakneck pace of healthcare innovation is proving difficult for HCPs to keep up with, a survey has revealed.
Johnson & Johnson Oncology commissioned The Harris Poll to survey 500 HCPs in the US who treat cancer to understand the challenges they face when delivering the latest innovations to patients.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.